医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Comprehensive strategies for management of postoperative hyper-progression recurrence(HPR)of hepatocellular carcinoma:a 12-year large sample multi-center study

摘要Objective:Hyper-progression recurrence(HPR)after hepatectomy is a specific recurrence pattern associated with extremely poor prognosis in patients with hepatocellular carcinoma(HCC).This study was aimed at investigating the probable risk factors and establishing comprehensive models for formulating clinical strategies.Methods:Overall,16,158 patients with HCC from 8 hospitals were screened,among whom 3,125 patients who underwent R0 resection were included,and divided into development(n=2,113)and validation(n=1,012)cohorts.A comprehensive study of HPR predictive models and biological features was conducted.Results:Among the 3,125 enrolled patients,506(16.19%)developed HPR.The influence of HPR on extremely poor prognosis was reflected by recurrence features,adverse effects on systemic and liver function,and limited therapeutic options.Nine variables closely associated with HPR were identified,and incorporated into nomogram and conditional inference tree models,which successfully achieved pre-and post-operative HPR risk stratification and facilitated clinical decision-making.Multi-dimensional verification also confirmed the predictive accuracy of model combinations and their reliability in clinical applications.Furthermore,biological analyses revealed that HCCs with HPR exhibited hyperactive biological processes,inactive metabolism,and immune exhaustion features,together with high MYCN/HMGA2 co-expression,thereby enhancing understanding of the molecular events leading to HPR and providing valuable knowledge for HPR management.Conclusions:HPR after hepatectomy is associated with extremely poor prognosis and requires substantial attention.We constructed comprehensive predictive models and propose a clinical strategy for guiding HPR prevention and management.

更多
广告
作者 Lunan Qi [1] Jingxuan Xu [2] Yuanyuan Chen [3] Zhan Lu [4] Min Zhou [5] Yingwu Huang [6] Yongchi Ling [7] Hai Huang [8] Yuchong Peng [9] Tao Peng [10] Bangde Xiang [1] Liang Ma [1] 学术成果认领
作者单位 Department of Hepatobiliary Surgery,Guangxi Medical University Cancer Hospital,Nanning 530021,China;Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor,Ministry of Education,Nanning 530021,China [1] Department of Hepatobiliary Surgery,Guangxi Medical University Cancer Hospital,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor,Ministry of Education,Nanning 530021,China [2] Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor,Ministry of Education,Nanning 530021,China;Department of Ultrasound,First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China [3] Department of Hepatobiliary Surgery,Guangxi Medical University Cancer Hospital,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor,Ministry of Education,Nanning 530021,China;Department of Hepatobiliary Surgery,Guangxi International Zhuang Medical Hospital,Nanning 530021,China [4] Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor,Ministry of Education,Nanning 530021,China;Department of General Surgery,Liuzhou Workers'Hospital,Liuzhou 545005,China [5] Department of Hepatobiliary Surgery,Chongzuo People's Hospital,Chongzuo 532200,China [6] Department of Surgery,Fusui County People's Hospital of Guangxi,Fusui 543200,China [7] Department of Hepatobiliary Surgery,Wuming Hospital of Guangxi Medical University,Wuming 530100,China [8] Department of General Surgery,Chongqing Hospital of Traditional Chinese Medicine,Chongqing 400021,China [9] Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor,Ministry of Education,Nanning 530021,China;Department of Hepatobiliary Surgery,First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China [10]
栏目名称
DOI 10.20892/j.issn.2095-3941.2024.0514
发布时间 2025-09-17(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览1
  • 下载1
癌症生物学与医学(英文版)

癌症生物学与医学(英文版)

2025年22卷8期

964-987页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷